135 related articles for article (PubMed ID: 21570636)
1. The new criteria for classification of rheumatoid arthritis: what we need to know for clinical practice.
Corrao S; Calvo L; Licata G
Eur J Intern Med; 2011 Jun; 22(3):217-9. PubMed ID: 21570636
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
[TBL] [Abstract][Full Text] [Related]
4. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
5. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
6. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
Russell AS; Devani A; Maksymowych WP
J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377
[TBL] [Abstract][Full Text] [Related]
7. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
Tant L; Steinfeld S
Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis].
Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S
Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342
[TBL] [Abstract][Full Text] [Related]
9. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).
Kastbom A; Strandberg G; Lindroos A; Skogh T
Ann Rheum Dis; 2004 Sep; 63(9):1085-9. PubMed ID: 15308517
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
11. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: a meta-analysis].
Huang QS; Wan LG; Luo ZQ; Le AP; Wang WQ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2182-7. PubMed ID: 17064503
[TBL] [Abstract][Full Text] [Related]
13. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
15. Does a positive anti-CCP test identify a distinct arthritis entity?
Skogh T
Arthritis Res Ther; 2005; 7(6):230-2. PubMed ID: 16277697
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
Ota T
Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
18. [New biomarkers for rheumatoid arthritis].
Hayashi N; Nishimura K; Kumagai S
Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
[TBL] [Abstract][Full Text] [Related]
19. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
[No Abstract] [Full Text] [Related]
20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
